Amazon customers are up in arms after the retailer replaced specific product names with generic labels in order emails, citing privacy concerns and a push to direct shoppers to its app and website.
A major bond market sell-off driven by rising U.S. debt and oil prices has pushed the 10-year Treasury yield to its highest level since 2023, threatening to increase borrowing costs for consumers, weaken stock returns, and further cool the job market.
BlackRock’s top US strategist advises investors to prepare for higher bond yields by shifting to short- and intermediate-duration bonds, adding dividend stocks, and focusing on quality companies with strong earnings growth and balance sheets.
Uber announces 10% corporate layoffs, impacting 3,300 staff, as it cuts management roles amid tech sector restructuring.
Tech giants borrowing heavily to fund AI infrastructure are competing with governments for investor capital, pushing bond yields to multi-decade highs and raising borrowing costs for consumers and businesses alike.
The federal government seized Anthropic shares from Sam Bankman-Fried’s associates, and as the AI company approaches a potential record-breaking IPO, questions arise about whether victims of the $11 billion fraud will ever see compensation from these billions in assets.
Leadership
Those who think they can double outputs with AI by simply doubling inputs are omitting approaching enterprise AI entirely backwards.
Just In
Anti-trust policy threatens the development of life-saving medicines. The FTC’s approach reflects a profound misunderstanding of the pharmaceutical industry and the market for innovation.
Editor's Picks
The New York Yankees have lost a special infielder to their crosstown rival New York Mets after a contract opt out.
Finance
Spend a day in the life of top CEOs, founders, and creatives. See how these business leaders start their morning, power through the day, and wind down.
Fintech
Verum Finance: A Super App for Private Finance Integrated Into a Messenger
Business
AI for mental health has a new target, namely assessing human therapists. Initial reactions oppose this. But there’s merit involved. Here’s the inside scoop.
